CoaguSense is the first PT/INR system to directly detect clot formation representing a breakthrough in PT/INR testing design simplicity.
Two million new people start taking the oral anticoagulant drug Warfarin every year to prevent blood clots, heart attacks and stroke. Correct dosing of Warfarin is determined for each patient by periodically measuring blood clotting time using the prothrombin time (PT) test. The simplicity of the new Coagu-Sense system offers clinicians not only the performance they require but also the reliability they demand. With the recent expansion in medicare coverage, most patients on Warfarin can now easily test their PT/INR with confidence in their own home.
Key Features
- A convenient tool for in-office testing
- Simple & accurate sample collection
- A more direct approach to INR testing
- It has CE Marking
